Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037922260> ?p ?o ?g. }
- W3037922260 endingPage "1372" @default.
- W3037922260 startingPage "1360" @default.
- W3037922260 abstract "An international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in eosinophilic granulomatosis with polyangiitis (EGPA) is presented. ANCA, specific for myeloperoxidase (MPO), can be detected in 30-35% of EGPA patients. MPO-ANCA should be tested with antigen-specific immunoassays in any patient with eosinophilic asthma and clinical features suggesting EGPA, including constitutional symptoms, purpura, polyneuropathy, unexplained heart, gastrointestinal or kidney disease, and/or pulmonary infiltrates or hemorrhage. A positive MPO-ANCA result contributes to the diagnostic work‑up for EGPA. Patients with MPO-ANCA associated EGPA have more frequently vasculitis features, such as glomerulonephritis, neuropathy, and skin manifestations than patients with ANCA negative EGPA. However, the presence of MPO-ANCA is neither sensitive nor specific enough to identify whether a patient should be subclassified as having vasculitic or eosinophilic EGPA. At present, ANCA status cannot guide treatment decisions, that is, whether cyclophosphamide, rituximab or mepolizumab should be added to conventional glucocorticoid treatment. In EGPA, monitoring of ANCA is only useful when MPO-ANCA was tested positive at disease onset." @default.
- W3037922260 created "2020-07-02" @default.
- W3037922260 creator A5000558528 @default.
- W3037922260 creator A5001643187 @default.
- W3037922260 creator A5007888588 @default.
- W3037922260 creator A5009125671 @default.
- W3037922260 creator A5010707925 @default.
- W3037922260 creator A5012967877 @default.
- W3037922260 creator A5022516530 @default.
- W3037922260 creator A5028156038 @default.
- W3037922260 creator A5028734074 @default.
- W3037922260 creator A5032065165 @default.
- W3037922260 creator A5034799657 @default.
- W3037922260 creator A5047141793 @default.
- W3037922260 creator A5066278285 @default.
- W3037922260 creator A5066638505 @default.
- W3037922260 creator A5066642738 @default.
- W3037922260 creator A5070674274 @default.
- W3037922260 creator A5071488467 @default.
- W3037922260 creator A5072612033 @default.
- W3037922260 creator A5075309120 @default.
- W3037922260 creator A5077185494 @default.
- W3037922260 creator A5080999925 @default.
- W3037922260 creator A5082548810 @default.
- W3037922260 creator A5083643588 @default.
- W3037922260 creator A5085617282 @default.
- W3037922260 creator A5089946412 @default.
- W3037922260 creator A5090075130 @default.
- W3037922260 creator A5090509034 @default.
- W3037922260 date "2020-11-15" @default.
- W3037922260 modified "2023-10-14" @default.
- W3037922260 title "International Consensus on Antineutrophil Cytoplasm Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis" @default.
- W3037922260 cites W1884365419 @default.
- W3037922260 cites W1972712879 @default.
- W3037922260 cites W1988708695 @default.
- W3037922260 cites W2001028378 @default.
- W3037922260 cites W2009925041 @default.
- W3037922260 cites W2011779958 @default.
- W3037922260 cites W2018105494 @default.
- W3037922260 cites W2031517139 @default.
- W3037922260 cites W2038284056 @default.
- W3037922260 cites W2039037177 @default.
- W3037922260 cites W2044380618 @default.
- W3037922260 cites W2051213302 @default.
- W3037922260 cites W2055085582 @default.
- W3037922260 cites W2063340779 @default.
- W3037922260 cites W2064940997 @default.
- W3037922260 cites W2072998173 @default.
- W3037922260 cites W2079613972 @default.
- W3037922260 cites W2082874877 @default.
- W3037922260 cites W2084056567 @default.
- W3037922260 cites W2086684697 @default.
- W3037922260 cites W2087681758 @default.
- W3037922260 cites W2097866139 @default.
- W3037922260 cites W2105921520 @default.
- W3037922260 cites W2108789073 @default.
- W3037922260 cites W2115453427 @default.
- W3037922260 cites W2115535632 @default.
- W3037922260 cites W2117243518 @default.
- W3037922260 cites W2128427657 @default.
- W3037922260 cites W2130911389 @default.
- W3037922260 cites W2132820210 @default.
- W3037922260 cites W2137507675 @default.
- W3037922260 cites W2140515181 @default.
- W3037922260 cites W2140729034 @default.
- W3037922260 cites W2150534327 @default.
- W3037922260 cites W2151789392 @default.
- W3037922260 cites W2162416852 @default.
- W3037922260 cites W2162759126 @default.
- W3037922260 cites W2163764420 @default.
- W3037922260 cites W2195097140 @default.
- W3037922260 cites W2283152765 @default.
- W3037922260 cites W2288077751 @default.
- W3037922260 cites W2297131172 @default.
- W3037922260 cites W2314315424 @default.
- W3037922260 cites W2339346940 @default.
- W3037922260 cites W2407601973 @default.
- W3037922260 cites W2474029657 @default.
- W3037922260 cites W2496249381 @default.
- W3037922260 cites W2526725029 @default.
- W3037922260 cites W2548261031 @default.
- W3037922260 cites W2567598347 @default.
- W3037922260 cites W2590549497 @default.
- W3037922260 cites W2615817830 @default.
- W3037922260 cites W2620870647 @default.
- W3037922260 cites W2756249964 @default.
- W3037922260 cites W2803856234 @default.
- W3037922260 cites W2807824120 @default.
- W3037922260 cites W282983221 @default.
- W3037922260 cites W2904700782 @default.
- W3037922260 cites W2905045302 @default.
- W3037922260 cites W2909763533 @default.
- W3037922260 cites W2948247751 @default.
- W3037922260 cites W2951131347 @default.
- W3037922260 cites W2958012222 @default.
- W3037922260 cites W2990014347 @default.
- W3037922260 cites W2997257220 @default.
- W3037922260 cites W3000599402 @default.